Regulation of epigenetic traits of the glutathione S-transferase P1 gene: From detoxification toward cancer prevention and diagnosis

Frontiers in Pharmacology

Volumn 5 JUL, Issue , 2014, Pages

  Schnekenburger, Michael ^a   Karius, Tommy ^a   Diederich, Marc ^b  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

^b Seoul National University   (South Korea)

Author keywords

Biomarker; Cancer; DNA methylation; Epigenetics; Epimutations; GSTP1; Histone modifications

Indexed keywords

GLUTATHIONE TRANSFERASE P1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR SP1;

BREAST CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PREVENTION; CANCER SUSCEPTIBILITY; CPG ISLAND; DETOXIFICATION; DNA DAMAGE; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; GENE FUNCTION; GENE LOCUS; GENE SILENCING; HEMATOLOGIC DISEASE; HISTONE MODIFICATION; HUMAN; LEUKEMIA; LIVER CANCER; LUNG CANCER; LYMPHOMA; MALIGNANT TRANSFORMATION; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

EID: 84904741347     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00170     Document Type: Review

References (73)

1. Bakker, J., Lin, X., and Nelson, W. G. (2002). Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells. J. Biol. Chem. 277, 22573-22580. doi: 10.1074/jbc.M203009200
2. Blancafort, P., Jin, J., and Frye, S. (2013). Writing and rewriting the epigenetic code of cancer cells: from engineered proteins to small molecules. Mol. Pharmacol. 83, 563-576. doi: 10.1124/mol.112.080697
3. Borde-Chiche, P., Diederich, M., Morceau, F., Puga, A., Wellman, M., and Dicato, M. (2001a). Regulation of transcription of the glutathione S-transferase P1 gene by methylation of the minimal promoter in human leukemia cells. Biochem. Pharmacol. 61, 605-612. doi: 10.1016/S0006-2952(00)00581-5
4. Borde-Chiche, P., Diederich, M., Morceau, F., Wellman, M., and Dicato, M. (2001b). Phorbol ester responsiveness of the glutathione S-transferase P1 gene promoter involves an inducible c-jun binding in human K562 leukemia cells. Leuk. Res. 25, 241-247. doi: 10.1016/S0145-2126(00)00118-1
5. Brooks, J. D., Weinstein, M., Lin, X., Sun, Y., Pin, S. S., Bova, G. S.,et al. (1998). CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol. Biomarkers Prev. 7, 531-536.
6. Cairns, P., Esteller, M., Herman, J. G., Schoenberg, M., Jeronimo, C., Sanchez-Cespedes, M.,et al. (2001). Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin. Cancer Res. 7, 2727-2730.
7. Cao, D. L., and Yao, X. D. (2010). Advances in biomarkers for the early diagnosis of prostate cancer. Chin. J. Cancer 29, 229-233. doi: 10.5732/cjc.009.10274
8. Chan, Q. K., Khoo, U. S., Chan, K. Y., Ngan, H. Y., Li, S. S., Chiu, P. M.,et al. (2005). Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinoma. J. Mol. Diagn. 7, 8-16. doi: 10.1016/S1525-1578(10)60003-7
9. Coughlin, S. S., and Hall, I. J. (2002a). Glutathione S-transferase polymorphisms and risk of ovarian cancer: a HuGE review. Genet. Med. 4, 250-257. doi: 10.1097/00125817-200207000-00003
10. Coughlin, S. S., and Hall, I. J. (2002b). A review of genetic polymorphisms and prostate cancer risk. Ann. Epidemiol. 12, 182-196. doi: 10.1016/S1047-2797(01)00310-6
11. Deep, J. S., Sidhu, S., Chandel, A., Thapliyal, S., and Garg, C. (2012). Aberrant Methylation in Promoters of GSTP1, p16, p14, and RASSF1A Genes in Smokers of North India. ISRN Pulmonol. 2012, 6. doi: 10.5402/2012/247631
12. Di Pietro, G., Magno, L. A., and Rios-Santos, F. (2010). Glutathione S-transferases: an overview in cancer research. Expert Opin. Drug Metab. Toxicol. 6, 153-170. doi: 10.1517/17425250903427980
13. Dumache, R., Miclea, F., Bumblacila, B., and Puiu, M. (2010). Clinical applications of molecular biomarkers in prostate cancer detection. Rev. Med. Chir. Soc. Med. Nat. Iasi 114, 470-475.
14. Duvoix, A., Delhalle, S., Blasius, R., Schnekenburger, M., Morceau, F., Fougere, M., et al. (2004a). Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition. Biochem. Pharmacol. 68, 1101-1111. doi: 10.1016/j.bcp.2004.05.032
15. Duvoix, A., Schnekenburger, M., Delhalle, S., Blasius, R., Borde-Chiche, P., Morceau, F.,et al. (2004b). Expression of glutathione S-transferase P1-1 in leukemic cells is regulated by inducible AP-1 binding. Cancer Lett. 216, 207-219. doi: 10.1016/j.canlet.2004.05.004
16. Duvoix, A., Morceau, F., Delhalle, S., Schmitz, M., Schnekenburger, M., Galteau, M. M.,et al. (2003a). Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition. Biochem. Pharmacol. 66, 1475-1483. doi: 10.1016/S0006-2952(03)00501-X
17. Duvoix, A., Schmitz, M., Schnekenburger, M., Dicato, M., Morceau, F., Galteau, M. M.,et al. (2003b). Transcriptional regulation of glutathione S-transferase P1-1 in human leukemia. Biofactors 17, 131-138. doi: 10.1002/biof.5520170113
18. Esteller, M. (2008). Epigenetics in cancer. N. Engl. J. Med. 358, 1148-1159. doi: 10.1056/NEJMra072067
19. Esteller, M., Sanchez-Cespedes, M., Rosell, R., Sidransky, D., Baylin, S. B., and Herman, J. G. (1999). Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 59, 67-70.
20. Ferlay, J., Parkin, D. M., and Steliarova-Foucher, E. (2010). Estimates of cancer incidence and mortality in Europe in 2008. Eur. J. Cancer 46, 765-781. doi: 10.1016/j.ejca.2009.12.014
21. Florean, C., Schnekenburger, M., Grandjenette, C., Dicato, M., and Diederich, M. (2011). Epigenomics of leukemia: from mechanisms to therapeutic applications. Epigenomics 3, 581-609. doi: 10.2217/epi.11.73
22. Hauptstock, V., Kuriakose, S., Schmidt, D., Duster, R., Muller, S. C., Von Ruecker, A.,et al. (2011). Glutathione-S-transferase pi 1(GSTP1) gene silencing in prostate cancer cells is reversed by the histone deacetylase inhibitor depsipeptide. Biochem. Biophys. Res. Commun. 412, 606-611. doi: 10.1016/j.bbrc.2011.08.007
23. Henderson, C. J., Mclaren, A. W., Moffat, G. J., Bacon, E. J., and Wolf, C. R. (1998). Pi-class glutathione S-transferase: regulation and function. Chem. Biol. Interact. 111-112, 69-82. doi: 10.1016/S0009-2797(97)00176-2
24. Henrique, R., and Jeronimo, C. (2004). Molecular detection of prostate cancer: a role for GSTP1 hypermethylation. Eur. Urol. 46, 660-669. doi: 10.1016/j.eururo.2004.06.014
25. Hopkins, T. G., Burns, P. A., and Routledge, M. N. (2007). DNA methylation of GSTP1 as biomarker in diagnosis of prostate cancer. Urology 69, 11-16. doi: 10.1016/j.urology.2006.10.008
26. Huang, J., Plass, C., and Gerhauser, C. (2011). Cancer chemoprevention by targeting the epigenome. Curr. Drug Targets 12, 1925-1956. doi: 10.2174/138945011798184155
27. Jaenisch, R., and Bird, A. (2003). Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33(Suppl.), 245-254. doi: 10.1038/ng1089
28. Jeronimo, C., Varzim, G., Henrique, R., Oliveira, J., Bento, M. J., Silva, C.,et al. (2002). I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 11, 445-450.
29. Jhaveri, M. S., and Morrow, C. S. (1998). Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells. Gene 210, 1-7. doi: 10.1016/S0378-1119(98)00021-3
30. Kanwal, R., Pandey, M., Bhaskaran, N., Maclennan, G. T., Fu, P., Ponsky, L. E.,et al. (2014). Protection against oxidative DNA damage and stress in human prostate by glutathione S-transferase P1. Mol. Carcinog. 53, 8-18. doi: 10.1002/mc.21939
31. Karius, T., Schnekenburger, M., Dicato, M., and Diederich, M. (2012). MicroRNAs in cancer management and their modulation by dietary agents. Biochem. Pharmacol. 83, 1591-1601. doi: 10.1016/j.bcp.2012.02.004
32. Karius, T., Schnekenburger, M., Ghelfi, J., Walter, J., Dicato, M., and Diederich, M. (2011). Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines. Biochem. Pharmacol. 81, 1329-1342. doi: 10.1016/j.bcp.2011.03.014
33. Ketterer, B. (1998). Glutathione S-transferases and prevention of cellular free radical damage. Free Radic. Res. 28, 647-658. doi: 10.3109/10715769809065820
34. Kim, J. H., Choi, Y. D., Lee, J. S., Lee, J. H., Nam, J. H., Choi, C.,et al. (2009). Borderline and malignant phyllodes tumors display similar promoter methylation profiles. Virchows Arch. 455, 469-475. doi: 10.1007/s00428-009-0858-z
35. Kim, Y. T., Park, S. J., Lee, S. H., Kang, H. J., Hahn, S., Kang, C. H.,et al. (2005). Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung. J. Thorac. Cardiovasc. Surg. 130, 1378. doi: 10.1016/j.jtcvs.2005.06.015
36. King-Batoon, A., Leszczynska, J. M., and Klein, C. B. (2008). Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ. Mol. Mutagen. 49, 36-45. doi: 10.1002/em.20363
37. Laborde, E. (2010). Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death. Cell Death Differ. 17, 1373-1380. doi: 10.1038/cdd.2010.80
38. Lin, X., and Nelson, W. G. (2003). Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells. Cancer Res. 63, 498-504.
39. Migicovsky, Z., and Kovalchuk, I. (2011). Epigenetic memory in mammals. Front. Genet. 2: 28. doi: 10.3389/fgene.2011.00028
40. Millar, D. S., Paul, C. L., Molloy, P. L., and Clark, S. J. (2000). A distinct sequence (ATAAA)n separates methylated and unmethylated domains at the 5'-end of the GSTP1 CpG island. J. Biol. Chem. 275, 24893-24899. doi: 10.1074/jbc.M906538199
41. Miyake, T., Nakayama, T., Naoi, Y., Yamamoto, N., Otani, Y., Kim, S. J.,et al. (2012). GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer. Cancer Sci. 103, 913-920. doi: 10.1111/j.1349-7006.2012.02231.x
42. Moffat, G. J., Mclaren, A. W., and Wolf, C. R. (1996). Sp1-mediated transcriptional activation of the human Pi class glutathione S-transferase promoter. J. Biol. Chem. 271, 1054-1060. doi: 10.1074/jbc.271.2.1054
43. Morceau, F., Chateauvieux, S., Gaigneaux, A., Dicato, M., and Diederich, M. (2013). Long and short non-coding RNAs as regulators of hematopoietic differentiation. Int. J. Mol. Sci. 14, 14744-14770. doi: 10.3390/ijms140714744
44. Morceau, F., Duvoix, A., Delhalle, S., Schnekenburger, M., Dicato, M., and Diederich, M. (2004). Regulation of glutathione S-transferase P1-1 gene expression by NF-kappaB in tumor necrosis factor alpha-treated K562 leukemia cells. Biochem. Pharmacol. 67, 1227-1238. doi: 10.1016/j.bcp.2003.10.036
45. Moriya, Y., Nohata, N., Kinoshita, T., Mutallip, M., Okamoto, T., Yoshida, S.,et al. (2012). Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma. J. Hum. Genet. 57, 38-45. doi: 10.1038/jhg.2011.126
46. Morrow, C. S., Cowan, K. H., and Goldsmith, M. E. (1989). Structure of the human genomic glutathione S-transferase-pi gene. Gene 75, 3-11. doi: 10.1016/0378-1119(89)90377-6
47. Mutallip, M., Nohata, N., Hanazawa, T., Kikkawa, N., Horiguchi, S., Fujimura, L.,et al. (2011). Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133alpha in head and neck squamous cell carcinoma (HNSCC). Int. J. Mol. Med. 27, 345-352. doi: 10.3892/ijmm.2010.589
48. Nakamichi, I., Tomita, Y., Zhang, B., Sugiyama, H., Kanakura, Y., Fukuhara, S.,et al. (2007). Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma. Ann. Hematol. 86, 557-564. doi: 10.1007/s00277-007-0299-1
49. Ohta, K., Ohigashi, M., Naganawa, A., Ikeda, H., Sakai, M., Nishikawa, J.,et al. (2007). Histone acetyltransferase MOZ acts as a co-activator of Nrf2-MafK and induces tumour marker gene expression during hepatocarcinogenesis. Biochem. J. 402, 559-566. doi: 10.1042/BJ20061194
50. Okino, S. T., Pookot, D., Majid, S., Zhao, H., Li, L. C., Place, R. F.,et al. (2007). Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer. Mol. Carcinog. 46, 839-846. doi: 10.1002/mc.20313
51. Pandey, M., Shukla, S., and Gupta, S. (2010). Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells. Int. J. Cancer 126, 2520-2533. doi: 10.1002/ijc.24988
52. Patron, J. P., Fendler, A., Bild, M., Jung, U., Muller, H., Arntzen, M. O.,et al. (2012). MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis. PLoS ONE 7:e35345. doi: 10.1371/journal.pone.0035345
53. Re, A., Aiello, A., Nanni, S., Grasselli, A., Benvenuti, V., Pantisano, V.,et al. (2011). Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-beta and endothelial nitric oxide synthase complex. Mol. Endocrinol. 25, 2003-2016. doi: 10.1210/me.2011-1024
54. Rossi, D., Capello, D., Gloghini, A., Franceschetti, S., Paulli, M., Bhatia, K.,et al. (2004). Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia. Haematologica 89, 154-164.
55. Ruscoe, J. E., Rosario, L. A., Wang, T., Gate, L., Arifoglu, P., Wolf, C. R.,et al. (2001). Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. J. Pharmacol. Exp. Ther. 298, 339-345.
56. Ruzza, P., Rosato, A., Rossi, C. R., Floreani, M., and Quintieri, L. (2009). Glutathione transferases as targets for cancer therapy. Anticancer Agents Med. Chem. 9, 763-777. doi: 10.2174/187152009789056895
57. Saxena, A., Dhillon, V. S., Shahid, M., Khalil, H. S., Rani, M., Prasad, D. T.,et al. (2012). GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients. Exp. Ther. Med. 4, 1097-1103. doi: 10.3892/etm.2012.710
58. Schnekenburger, M., Dicato, M., and Diederich, M. (2014). Plant-derived epigenetic modulators for cancer treatment and prevention. Biotechnol. Adv. doi: 10.1016/j.biotechadv.2014.03.009 [Epub ahead of print].
59. Schnekenburger, M., and Diederich, M. (2012). Epigenetics offer new horizons for colorectal cancer prevention. Curr. Colorectal Cancer Rep. 8, 66-81. doi: 10.1007/s11888-011-0116-z
60. Schnekenburger, M., Morceau, F., Duvoix, A., Delhalle, S., Trentesaux, C., Dicato, M.,et al. (2003). Expression of glutathione S-transferase P1-1 in differentiating K562: role of GATA-1. Biochem. Biophys. Res. Commun. 311, 815-821.
61. Schnekenburger, M., Morceau, F., Duvoix, A., Delhalle, S., Trentesaux, C., Dicato, M.,et al. (2004). Increased glutathione S-transferase P1-1 expression by mRNA stabilization in hemin-induced differentiation of K562 cells. Biochem. Pharmacol. 68, 1269-1277. doi: 10.1016/j.bcp.2004.03.047
62. Seidel, C., Florean, C., Schnekenburger, M., Dicato, M., and Diederich, M. (2012). Chromatin-modifying agents in anti-cancer therapy. Biochimie 94, 2264-2279. doi: 10.1016/j.biochi.2012.05.012
63. Smith, Z. D., and Meissner, A. (2013). DNA methylation: roles in mammalian development. Nat. Rev. Genet. 14, 204-220. doi: 10.1038/nrg3354
64. Terrier, P., Townsend, A. J., Coindre, J. M., Triche, T. J., and Cowan, K. H. (1990). An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am. J. Pathol. 137, 845-853.
65. Uchida, Y., Chiyomaru, T., Enokida, H., Kawakami, K., Tatarano, S., Kawahara, K.,et al. (2013). MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines. Urol. Oncol. 31, 115-123. doi: 10.1016/j.urolonc.2010.09.017
66. Vardi, A., Bosviel, R., Rabiau, N., Adjakly, M., Satih, S., Dechelotte, P.,et al. (2010). Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells. In Vivo 24, 393-400.
67. Wang, T., Arifoglu, P., Ronai, Z., and Tew, K. D. (2001). Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J. Biol. Chem. 276, 20999-21003. doi: 10.1074/jbc.M101355200
68. Wu, Y., Fan, Y., Xue, B., Luo, L., Shen, J., Zhang, S.,et al. (2006). Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 25, 5787-5800. doi: 10.1038/sj.onc.1209576
69. Xiang, N., Zhao, R., Song, G., and Zhong, W. (2008). Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells. Carcinogenesis 29, 2175-2181. doi: 10.1093/carcin/bgn179
70. Yang, M., and Park, J. Y. (2012). DNA methylation in promoter region as biomarkers in prostate cancer. Methods Mol. Biol. 863, 67-109. doi: 10.1007/978-1-61779-612-8_5
71. Yuan, Y., Qian, Z. R., Sano, T., Asa, S. L., Yamada, S., Kagawa, N.,et al. (2008). Reduction of GSTP1 expression by DNA methylation correlates with clinicopathological features in pituitary adenomas. Mod. Pathol. 21, 856-865. doi: 10.1038/modpathol.2008.60
72. Zeisel, S. H. (2012). Dietary choline deficiency causes DNA strand breaks and alters epigenetic marks on DNA and histones. Mutat. Res. 733, 34-38. doi: 10.1016/j.mrfmmm.2011.10.008
73. Zhang, X., Zhu, J., Xing, R., Tie, Y., Fu, H., Zheng, X.,et al. (2012). miR-513a-3p sensitizes human lung adenocarcinoma cells to chemotherapy by targeting GSTP1. Lung Cancer 77, 488-494. doi: 10.1016/j.lungcan.2012.05.107